­
­
­
­

Inventi Impact: Psychiatry & Neurology

Articles

  • Inventi:hpyn/46702/22
    Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic
    01-Jan-2023 Review 2023 : January-March
    Jennifer K Matsui, Haley K Perlow, Cyril Baiyee, Alex R Ritter, Mark V Mishra, Joseph A Bovi, Vinai Gondi, Paul D Brown, Ashlee R Loughan, Heather E Leeper, Erica Dawson, Joshua D Palmer

    Brain metastases (BMs) account for a disproportionately high percentage of cancer morbidity and mortality. Historically, studies have focused on improving survival outcomes, and recent radiation oncology clinical trials have incorporated HRQOL and cognitive assessments. We are now equipped with a battery of assessments in the radiation oncology clinic, but there is a lack of consensus regarding how to incorporate them in modern clinical practice. Herein, we present validated assessments for BM patients, current recommendations for future clinical studies, and treatment advances that have improved HRQOL and cognitive outcomes for BM patients.

    How to Cite this Article
    Attribution/ CC Compliant Citation: Matsui, Jennifer K., et al. "Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic." Cancers 14.17 (2022): 4301. https://doi.org/10.3390/cancers14174301; http://creativecommons.org/licenses/by/4.0/ Some formatting elements, header, footer, logos, dates and pagination were modified while adapting this article.
    Download Full Text